• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙戊酸的β-葡萄糖醛酸酶抗性“葡萄糖醛酸苷”在大鼠胆管内给药后的处置:完整吸收、粪便排泄和肠道水解

Disposition of beta-glucuronidase-resistant "glucuronides" of valproic acid after intrabiliary administration in the rat: intact absorption, fecal excretion and intestinal hydrolysis.

作者信息

Dickinson R G, Kluck R M, Eadie M J, Hooper W D

出版信息

J Pharmacol Exp Ther. 1985 Apr;233(1):214-21.

PMID:3920383
Abstract

The major metabolite of valproic acid (VPA) is its beta-glucuronidase-susceptible glucuronide conjugate (VPA-G). At slightly alkaline pH such as in bile, VPA-G undergoes intramolecular rearrangement into at least six beta-glucuronidase-resistant isomers (VPA-G-R). The in vivo disposition of VPA-G-R was compared with those of VPA-G and VPA, each at 100 mg of VPA per kg, after intrabiliary administration to surgically prepared rats fasted during the experiments. Administered VPA was rapidly and completely absorbed into blood (peak 30 micrograms of VPA per ml at 0-2 hr). Administered VPA-G was predominantly hydrolyzed (beta-glucuronidase) in the intestine and liberated VPA absorbed into blood (peak 5 micrograms of VPA per ml at 6-9 hr). Administered VPA-G-R was disposed along at least three pathways: (1) part excretion, mainly unchanged, in feces (12% of dose); (2) part absorption (intact) from gut to blood and excretion in urine as VPA-G-R (3.6% of dose); and (3) part hydrolysis in the intestine (most likely by nonspecific esterases) with absorption of liberated VPA into blood (peak 2 micrograms of VPA per ml at 12-24 hr). The VPA/VPA-G/VPA-G-R composition of recovered dose in bile and urine was determined after all doses. In fed, nontraumatized rats given VPA-G-R p.o. at 100 mg of VPA per kg, 50% of the dose was recovered (mainly unchanged) in feces, a portion was absorbed intact into blood (2.5% of dose VPA-G-R excreted in urine) and the remainder hydrolyzed in the intestine with absorption of liberated VPA into blood.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

丙戊酸(VPA)的主要代谢产物是其对β-葡萄糖醛酸酶敏感的葡萄糖醛酸共轭物(VPA-G)。在略碱性的pH值下,如在胆汁中,VPA-G会发生分子内重排,形成至少六种对β-葡萄糖醛酸酶有抗性的异构体(VPA-G-R)。在实验期间对手术制备的禁食大鼠进行胆管内给药后,比较了VPA-G-R与VPA-G和VPA的体内处置情况,每种给药剂量均为每千克体重100毫克VPA。给药的VPA迅速且完全吸收进入血液(0 - 2小时时峰值为每毫升30微克VPA)。给药的VPA-G主要在肠道中被水解(β-葡萄糖醛酸酶作用),释放出的VPA吸收进入血液(6 - 9小时时峰值为每毫升5微克VPA)。给药的VPA-G-R至少通过三条途径进行处置:(1)部分排泄,主要为原形,通过粪便排出(占剂量的12%);(2)部分从肠道完整吸收进入血液,并以VPA-G-R形式经尿液排泄(占剂量的3.6%);(3)部分在肠道中水解(很可能由非特异性酯酶作用),释放出的VPA吸收进入血液(12 - 24小时时峰值为每毫升2微克VPA)。在所有剂量给药后,测定了胆汁和尿液中回收剂量的VPA/VPA-G/VPA-G-R组成。在给予每千克体重100毫克VPA的VPA-G-R口服给药的非创伤性进食大鼠中,50%的剂量在粪便中回收(主要为原形),一部分完整吸收进入血液(2.5%的剂量VPA-G-R经尿液排泄),其余部分在肠道中水解,释放出的VPA吸收进入血液。(摘要截选至250词)

相似文献

1
Disposition of beta-glucuronidase-resistant "glucuronides" of valproic acid after intrabiliary administration in the rat: intact absorption, fecal excretion and intestinal hydrolysis.丙戊酸的β-葡萄糖醛酸酶抗性“葡萄糖醛酸苷”在大鼠胆管内给药后的处置:完整吸收、粪便排泄和肠道水解
J Pharmacol Exp Ther. 1985 Apr;233(1):214-21.
2
Impaired biliary elimination of beta-glucuronidase-resistant "glucuronides" of valproic acid after intravenous administration in the rat. Evidence for oxidative metabolism of the resistant isomers.
Drug Metab Dispos. 1986 Mar-Apr;14(2):255-62.
3
pH-dependent rearrangement of the biosynthetic ester glucuronide of valproic acid to beta-glucuronidase-resistant forms.丙戊酸生物合成酯葡萄糖醛酸苷的pH依赖性重排为抗β-葡萄糖醛酸酶形式。
Drug Metab Dispos. 1984 Mar-Apr;12(2):247-52.
4
Disposition of valproic acid in the rat: dose-dependent metabolism, distribution, enterohepatic recirculation and choleretic effect.
J Pharmacol Exp Ther. 1979 Dec;211(3):583-95.
5
Identification of valproic acid glucuronide hydrolase as a key enzyme for the interaction of valproic acid with carbapenem antibiotics.鉴定丙戊酸葡萄糖醛酸苷水解酶为丙戊酸与碳青霉烯类抗生素相互作用的关键酶。
Drug Metab Dispos. 2010 Sep;38(9):1538-44. doi: 10.1124/dmd.110.032938. Epub 2010 Jun 15.
6
Panipenem, a carbapenem antibiotic, enhances the glucuronidation of intravenously administered valproic acid in rats.帕尼培南是一种碳青霉烯类抗生素,可增强大鼠静脉注射丙戊酸的葡萄糖醛酸化作用。
Drug Metab Dispos. 1999 Jun;27(6):724-30.
7
Studies on the reactivity of acyl glucuronides--III. Glucuronide-derived adducts of valproic acid and plasma protein and anti-adduct antibodies in humans.酰基葡萄糖醛酸苷的反应活性研究——III. 丙戊酸与血浆蛋白的葡萄糖醛酸苷衍生加合物及人体内的抗加合物抗体
Biochem Pharmacol. 1992 Feb 18;43(4):745-55. doi: 10.1016/0006-2952(92)90239-f.
8
Studies of the enterohepatic circulation of morphine in the rat.大鼠体内吗啡肝肠循环的研究。
J Pharmacol Exp Ther. 1975 Nov;195(2):303-10.
9
Characterization of inhibitory effect of carbapenem antibiotics on the deconjugation of valproic acid glucuronide.分析碳青霉烯类抗生素对丙戊酸葡萄糖醛酸苷去轭反应的抑制作用。
Drug Metab Dispos. 2010 Oct;38(10):1828-35. doi: 10.1124/dmd.110.034231. Epub 2010 Jun 25.
10
Bioactivation of a toxic metabolite of valproic acid, (E)-2-propyl-2,4-pentadienoic acid, via glucuronidation. LC/MS/MS characterization of the GSH-glucuronide diconjugates.丙戊酸的一种有毒代谢物(E)-2-丙基-2,4-戊二烯酸通过葡萄糖醛酸化的生物活化作用。谷胱甘肽-葡萄糖醛酸二缀合物的液相色谱/串联质谱表征。
Chem Res Toxicol. 1996 Mar;9(2):517-26. doi: 10.1021/tx950120y.

引用本文的文献

1
Effect of aging on glucuronidation of valproic acid in human liver microsomes and the role of UDP-glucuronosyltransferase UGT1A4, UGT1A8, and UGT1A10.衰老对人肝微粒体中丙戊酸葡萄糖醛酸化的影响以及尿苷二磷酸葡萄糖醛酸基转移酶UGT1A4、UGT1A8和UGT1A10的作用。
Drug Metab Dispos. 2009 Jan;37(1):229-36. doi: 10.1124/dmd.108.022426. Epub 2008 Oct 6.
2
Biliary excretion of diflunisal conjugates in patients with T-tube drainage.
Eur J Clin Pharmacol. 1988;34(4):423-6. doi: 10.1007/BF00542448.
3
Physiologic and metabolic influences on enterohepatic recirculation: simulations based upon the disposition of valproic acid in the rat.生理和代谢对肝肠循环的影响:基于丙戊酸在大鼠体内处置情况的模拟
J Pharmacokinet Biopharm. 1991 Apr;19(2):189-225. doi: 10.1007/BF01073869.